Table 2.
Synthesis of psoriasis proposed treatments including reporting reference number, first author surname, year of publication, population risk factors reported in each study and the type of psoriasis
Ref. | Year | Study type | Studied population | Proposed treatment | Type of psoriasis |
Barrea et al[32], Phan et al[33] | 2015, 2018 | Cohort | Human | Dietary antioxidants (omega 3 polyunsatured fatty acids derived from fish oil, vitamin B12, vitamin D and selenium) | Not specified |
Subbiah et al[55] | 2010 | Review | - | Low-energy diets, vegetarian diets, formula diet weight loss programs, gluten-free or very low-calorie carbohydrate-free diet | Not specified |
Subbiah et al[55], Lin et al[85] | 2010, 2016 | Review | - | Dietary antioxidants: Vitamins (A, E and C), and oligo-elements (iron, copper, manganese, zinc, and selenium) | Not specified |
Murzaku et al[61], Upala et al[62], Morken et al[63] | 2014, 2017, 2011 | Review, systematic review, pilot study | Human | Omega-3 polyunsaturated fatty acids | Not specified |
Yang et al[67] | 2018 | RCT | Animal – mice | Nobiletin (Nob) and 5-hydroxy-6,7,8,3′,4′-pentamethoxyflavone (5-HPMF) | Not specified |
Arbiser et al[69] | 2017 | RCT | Animal - mice | Topical administration of solenopsin analogs | Not specified |
Gueniche et al[77] | 2014 | RCT | Human | Oral supplementation with the probiotic Lactobacillus paracasei | Not specified |
Eppinga et al[78] | 2014 | Review | - | Th17, TNF-α and IL-22 inhibitors | Psoriatic arthritis |
Castelino et al[79] | 2014 | Review | - | Transplant of fecal microbiome | Psoriatic arthritis |
RCT: Randomized controlled trial; TNF: Tumor necrosis factor; IL: Interleukin 1.